GlassScriptPhysician profile
Jed H Horowitz
NPI 1053494807
$10,184.56
in general payments reported to CMS, 2019-2025
18 companies · $2,746 in 2025
The $2,746 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,897 · 2020: $517 · 2021: $968 · 2022: $1,823 · 2023: $916 · 2024: $1,318 · 2025: $2,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,951 · Grant: $1,750 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,951.48 |
| Grant | $1,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,279.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,018.98 | 2023-2025 | |
| Sientra, INC. | $1,809.94 | 2019-2022 | |
| Allergan, INC. | $1,358.49 | 2019-2022 | |
| Tepha INC | $965.52 | 2019 | |
| Mentor Worldwide LLC | $437.47 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Tela Bio, INC. | $332.34 | 2022-2024 | Ovitex 2s |
| Acelrx Pharmaceuticals, INC. | $170.64 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $169.13 | 2022-2024 | Exparel, Iovera |
| Polynovo North America LLC | $164.56 | 2024 | Novosorb Btm |
| Davol INC. | $164.19 | 2022 | |
| Smith+Nephew, INC. | $132.06 | 2022 | |
| Innovation Technologies INC | $118.89 | 2020 | |
| Merz North America, INC. | $90.02 | 2022 | |
| Galderma Laboratories, L.P. | $68.33 | 2019-2024 | |
| Integra Lifesciences Corporation | $65.95 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $49.98 | 2025 | |
| Apyx Medical Corporation | $46.96 | 2019-2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jed Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.